MMCAP Infuse Influenza Vaccines (Statewide)

Ended Commodity contract New York Awarded

Contract number
PGB-23290
IDV awards
1

Vehicle facts

End date
Available to
All State Agencies and Political Subdivisions

Vehicle details come from ogs.ny.gov. Updated .

About this vehicle

The MMCAP Infuse Influenza Vaccines statewide contract provides authorized New York state agencies and political subdivisions with a comprehensive procurement vehicle for influenza vaccines manufactured by Sanofi Pasteur Inc. The contract enables users to purchase a selection of vaccines through a streamlined, cooperative purchasing mechanism. Specifically designed for public health entities, this procurement solution offers electronic ordering capabilities through www.vaccineshoppe.com, with additional incentives such as 1% savings for online orders and a 2% discount for prompt payment within 30 days.

The contract is a piggyback agreement derived from the Master Contract MMS2200727 between MMCAP Infuse and Sanofi Pasteur Inc., based in Swiftwater, PA. The contract period spans from March 27, 2023, to December 31, 2025, covering the 2023-2024 and 2024-2025 influenza vaccine seasons. As a statewide contract, it serves all New York state agencies and political subdivisions, with no minimum order requirements or additional charges. The contract type is classified as a commodity contract, and notably, it has 0% goals for Minority-owned Business Enterprise (MBE), Women-owned Business Enterprise (WBE), and Service-Disabled Veteran-owned Business (SDVOB) participation.

The individual IDV (PC69850 (Sanofi Pasteur Inc.)) is awarded exclusively to Sanofi Pasteur Inc. and provides an estimated quantity contract with no guaranteed purchase volumes. Authorized users can purchase vaccines at predetermined pricing, with the flexibility to seek alternative sources if more economically advantageous terms are available. The contract includes comprehensive insurance requirements for Sanofi Pasteur, covering commercial general liability, professional liability, data breach/cyber liability, and business automobile liability. Users can return up to 15% of each vaccine presentation for full credit, and the contract offers flexibility in order placement, modification, and cancellation prior to shipment.

Description

This award offers authorized users a selection of influenza vaccines manufactured by Sanofi Pasteur Inc. It is a Piggyback Contract off the Master Contract MMS2200727 between MMCAP Infuse (formerly the Minnesota Multistate Contracting Alliance for Pharmacy or "MMCAP") and Sanofi Pasteur Inc. Authorized users should contact the Contract Management Specialist named herein with any questions. This Award has 0% MBE, 0% WBE and 0% SDVOB goal requirements.

IDV awards

Awardee IDV award Awarded Ends
Sanofi Pasteur Inc. PC69850

Files

File Type Posted
1020023290PL_Sanofi.pdf PDF
1020023290ra.pdf PDF
1020023290TC_Sanofi.pdf PDF
1020023290p.pdf PDF

Quick answers

Who can buy from contract PGB-23290?

All State Agencies and Political Subdivisions can buy from contract PGB-23290.

Which companies hold contract PGB-23290?

Sanofi Pasteur Inc. holds contract PGB-23290.

On GovTribe

See this vehicle's full record

  • Every contract and award under it, and every file
  • Track it in your pipeline
  • Similar state and local vehicles and opportunities
  • Ask GovTribe AI about this vehicle